The influence of arterial hypertension on the development of coronary artery disease in angiographic findings;Wpływ nadciśnienia tȩtniczego na rozwój choroby wieńcowej w ocenie angiograficznej

Nadcisnienie Tetnicze

Volumn 10, Issue 3, 2006, Pages 215-221

  Arkowski, Jacek ^a   Derkacz, Arkadiusz ^a   Nowosad, Halina ^b  

^a Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Arterial hypertension; Coronary angiography; Coronary atherosclerosis

Indexed keywords

ANGIOGRAPHY; ARTERY DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTENSION; MORPHOLOGICAL TRAIT; REVIEW; VASCULARIZATION;

EID: 33747587265     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. MacMahon S., Peto R., Cutler J. i wsp. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
2. Franklin S.S., Larson M.G., Khan S.A. i wsp. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001; 103: 1245-1249.
3. Borghi C., Dormi A., L'Italien G. i wsp. The relationship between systolic blood pressure and cardiovascular risk - results of the Brisighella Heart Study. J. Clin. Hypertens. (Greenwich) 2003; 5: 47-52.
4. Vasan R.S., Massaro J.M., Wilson P.W. i wsp. Framingham Heart Study. Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Circulation 2002; 105: 48-53.
5. MacMahon S., Cutler J.A., Stamler J. Antihypertensive drug treatment. Potential, expected, and observed effects on stroke and on coronary heart disease. Hypertension 1989; 13 (5 supl. I): 45-50.
6. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2567.
7. Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC. Blood Press 2003; 12: 196-197.
8. ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J. Hypertens. 2003; 21: 1779-1786.
9. Williams G.H. Hypertensive Vascular Disease. W: Braunwald E., Fauci A.S., Kasper D.L. i wsp. (red.). Harrison's principles of internal medicine. Wyd. 15. McGrawHill, New York 2001, 1414-1430.
10. Zdrojewski T., Bandosz P., Wyrzykowski B. Nadciśnienie tȩtnicze w Polsce a aktualne zalecenia towarzystw europejskich w zakresie prewencji chorób układu kra̧zenia. Terapia 2004; 12 (7-8): 7-11.
11. Kawecka-Jaszcz K., Jankowski P., Paja̧k A., Bilo G., Czarnecka D. Czȩstośc i leczenie nadciśnienia tȩtniczego u osób hospitalizowanych z powodu choroby niedokrwiennej serca. Krakowski program wtórnej prewencji choroby niedokrwiennej serca. Nadciśnienie Tȩtnicze 2002; 6: 253-262.
12. Jankowski P., Kawecka-Jaszcz K., Czarnecka D. i wsp. Ascending aortic, but not brachial blood pressure-derived indices are related to coronary atherosclerosis. Atherosclerosis 2004; 176: 151-155.
13. Csanady M., Kovacs Z., Forster T., Neu K., Nemes A. Rezerwa przepływu wieńcowego jest zmniejszona w nadciśnieniowym przeroście lewej komory. Kardiologia Polska 2005; 62: 5-8.
14. Nitenberg A., Chemla D., Antony I. Epicardial coronary artery constriction to cold pressor test is predictive of cardiovascular events in hypertensive patients with angiographically normal coronary arteries and without other major coronary risk factor. Atherosclerosis 2004; 173: 115-123.
15. De Cesare N., Polese A., Cozzi S. i wsp. Coronary angiographic patterns in hypertensive compared with normotensive patients. Am. Heart J. 1991; 121: 1101-1106.
16. Natali A., Vichi S., Landi P. i wsp. Coronary artery disease and arterial hypertension: clinical, angiographic and follow-up data. J. Intern. Med. 2000; 247: 219-230.
17. Sanchez Torres G., Trevethan Craviotto S., Bialostozky D., Gutierrez Fuster E., Olvera Cruz S. Clinical and coronary angiographic characteristics of hypertensive angina. Arch. Inst. Cardiol. Mex. 1981; 51: 541-547.
18. Wang X.L., Tam C., McCredie R.M., Wilcken D.E. Determinants of severity of coronary artery disease in Australian men and women. Circulation 1994; 89: 1974-1981.
19. Kato J., Aihara A., Kikuya M. i wsp. Risk factors and predictors of coronary arterial lesions in Japanese hypertensive patients. Hypertens. Res. 2001; 24: 3-11.
20. Ogawa K., Numao T., Jizuka M. i wsp. Angiographic and coronary risk factor analyses of Japanese patients with ischemic heart disease before age 40 - a multicenter cooperative study. Jpn. Circ. J. 1996; 60: 822-830.
21. Fallow G.D., Singh J. The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: a matched-paired retrospective analysis using coronary angiography as the diagnostic tool. Mol. Cell Biochem. 2004; 261: 263-269.
22. Cariou B., Bonnevie L., Mayaudon H., Dupuy O., Ceccaldi B., Bauduceau B. Angiographic characteristics of coronary artery disease in diabetic patients compared with matched non-diabetic subjects. Diabetes Nutr. Metab. 2000; 13: 134-141.
23. Valsania P., Zarich S.W., Kowalchuk G.J., Kosinski E., Warram J.H., Krolewski A.S. Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus. Am. Heart J. 1991; 122: 695-700.
24. Kasaoka S., Okuda F., Satoh A. i wsp. Effect of coronary risk factors on coronary angiographie morphology in patients with ischemic heart disease. Jpn. Circ. J. 1997; 61: 390-395.
25. Yang X.L., Chen J., Zhou Y.L., Huang W.H., Luo J.F., Li G. Effect of hypertension on the morphology of coronary artery: analysis of 203 cases. Di Yi Jun Yi Da Xue Xue Bao 2004; 24: 226-227.
26. Frielingsdorf J., Kaufmann P., Seiler C. Abnormal coronary vasomotion in hypertension: role of coronary artery disease. J. Am. Coll. Cardiol. 1996; 28: 935-941.
27. Antony I., Nitenberg A. Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries. Am. J. Hypertens. 1997; 10: 181-188.
28. Frielingsdorf J., Seiler C., Kaufmann P., Vassalli G., Suter T., Hess O.M. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation 1996; 93: 1380-1387.
29. Brush J.E. Jr, Faxon D.P., Salmon S., Jacobs AK, Ryan T.J. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J. Am. Coll. Cardiol. 1992; 19: 809-815.
30. Hamasaki S., Al Suwaidi J., Higano S.T., Miyauchi K., Holmes D.R. Jr, Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J. Am. Coll. Cardiol. 2000; 35: 1654-1660.